Cell
Volume 163, Issue 3, 22 October 2015, Pages 746-758
Journal home page for Cell

Article
Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity

https://doi.org/10.1016/j.cell.2015.09.056Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Mitogenicity and antiviral activity of a lectin can be uncoupled via mutagenesis

  • The resultant lectin retains potent, broad-spectrum antiviral activity

  • Pi-pi stacking of two aromatic amino acids is necessary for mitogenicity

Summary

A key effector route of the Sugar Code involves lectins that exert crucial regulatory controls by targeting distinct cellular glycans. We demonstrate that a single amino-acid substitution in a banana lectin, replacing histidine 84 with a threonine, significantly reduces its mitogenicity, while preserving its broad-spectrum antiviral potency. X-ray crystallography, NMR spectroscopy, and glycocluster assays reveal that loss of mitogenicity is strongly correlated with loss of pi-pi stacking between aromatic amino acids H84 and Y83, which removes a wall separating two carbohydrate binding sites, thus diminishing multivalent interactions. On the other hand, monovalent interactions and antiviral activity are preserved by retaining other wild-type conformational features and possibly through unique contacts involving the T84 side chain. Through such fine-tuning, target selection and downstream effects of a lectin can be modulated so as to knock down one activity, while preserving another, thus providing tools for therapeutics and for understanding the Sugar Code.

Cited by (0)

14

Co-first author

15

Co-senior author